Compounds > sulforaphane
Page last updated: 2024-08-16

sulforaphane and ovalbumin

sulforaphane has been researched along with ovalbumin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (60.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Chung, SW; Heo, DR; Jung, ID; Kim, JW; Kim, YD; Lee, CM; Noh, KT; Park, JH; Park, JW; Park, YM; Seo, JK; Shin, YK1
Hayashi, SY; Hizawa, N; Ishii, Y; Kawaguchi, M; Kiwamoto, T; Matsuno, Y; Morishima, Y; Nakajima, M; Sakurai, H; Tsunoda, Y; Yamamoto, M; Yoshida, K1
Biswal, S; Chen, M; Dobzanski, A; Han, AH; Lane, AP; London, NR; Mendiola, M; Ramanathan, M; Sidhaye, V; Sussan, TE; Tharakan, A; Zaykaner, M1
Bambery, KR; Karagiannis, TC; Licciardi, PV; Mazarakis, N; Royce, SG; Samuel, CS; Snibson, KJ; Tobin, MJ; Ververis, K; Vongsvivut, J1
Beh, RC; Bourke, JE; Donovan, C; El-Osta, A; Hung, A; Karagiannis, TC; Khurana, I; Liang, JJ; Licciardi, PV; Maxwell, S; Mazarakis, N; Pitsillou, E; Royce, SG; Samuel, CS; Siow, YY; Snibson, KJ; Tang, MLK; Tobin, MJ; Ververis, K; Vongsvivut, J; Ziemann, M1

Other Studies

5 other study(ies) available for sulforaphane and ovalbumin

ArticleYear
Sulforaphane inhibits the Th2 immune response in ovalbumin-induced asthma.
    BMB reports, 2012, Volume: 45, Issue:5

    Topics: Animals; Anti-Inflammatory Agents; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Down-Regulation; Drug Evaluation, Preclinical; Egg Hypersensitivity; Female; Isothiocyanates; Lymphocyte Activation; Lymphocyte Count; Mice; Mice, Inbred BALB C; Ovalbumin; Sulfoxides; Th2 Cells

2012
Sulforaphane ameliorates steroid insensitivity through an Nrf2-dependent pathway in cigarette smoke-exposed asthmatic mice.
    Free radical biology & medicine, 2018, Volume: 129

    Topics: Animals; Anti-Asthmatic Agents; Asthma; Dexamethasone; Disease Models, Animal; Drug Combinations; Female; Gene Expression Regulation; Histone Deacetylase 2; Isothiocyanates; Lung; Mice; Mice, Inbred BALB C; Mice, Knockout; Nicotiana; Nuclear Respiratory Factor 1; Ovalbumin; Oxidative Stress; RNA, Messenger; Signal Transduction; Sulfoxides; Tobacco Smoke Pollution

2018
Nrf2 activation via Keap1 deletion or sulforaphane treatment reduces Ova-induced sinonasal inflammation.
    Allergy, 2019, Volume: 74, Issue:9

    Topics: Allergens; Animals; Disease Models, Animal; Disease Susceptibility; Humans; Isothiocyanates; Kelch-Like ECH-Associated Protein 1; Mice, Transgenic; NF-E2-Related Factor 2; Ovalbumin; Sinusitis; Sulfoxides

2019
Investigation of molecular mechanisms of experimental compounds in murine models of chronic allergic airways disease using synchrotron Fourier-transform infrared microspectroscopy.
    Scientific reports, 2020, 07-16, Volume: 10, Issue:1

    Topics: Animals; Anti-Asthmatic Agents; Asthma; Chronic Disease; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Hydroxamic Acids; Isothiocyanates; Mice; Mice, Inbred BALB C; Ovalbumin; Relaxin; Resveratrol; Spectroscopy, Fourier Transform Infrared; Sulfoxides; Synchrotrons; Treatment Outcome; Valproic Acid

2020
Sulforaphane prevents and reverses allergic airways disease in mice via anti-inflammatory, antioxidant, and epigenetic mechanisms.
    Cellular and molecular life sciences : CMLS, 2022, Nov-01, Volume: 79, Issue:11

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Epigenesis, Genetic; Humans; Hypersensitivity; Leukocytes, Mononuclear; Mice; Ovalbumin

2022